Financial Performance - The group's revenue for the fiscal year ended December 31, 2022, was HKD 1,186.2 million, an increase of 33.4% compared to HKD 888.9 million for the fiscal year ended December 31, 2021[2]. - Gross profit for the fiscal year 2022 was HKD 261.5 million, up 72.4% from HKD 151.7 million in 2021[2]. - The gross profit margin increased by 4.9 percentage points from 17.1% in 2021 to 22.0% in 2022[2]. - The net profit for the fiscal year 2022 was HKD 43.6 million, reversing a loss of HKD 17.4 million in 2021[2]. - Total reported segment revenue for 2022 was HKD 1,220,973,000, a 35.0% increase compared to HKD 905,235,000 in 2021[14]. - The group reported a net profit of HKD 43,631,000 for the year, recovering from a loss of HKD 17,402,000 in the previous year[15]. - The group's net profit attributable to shareholders was HKD 43.8 million for the fiscal year, a turnaround from a loss of HKD 18.8 million in the 2021 fiscal year, driven by increased revenue and reduced inventory write-downs[47]. Revenue Breakdown - E-commerce segment revenue for 2022 reached HKD 738,673,000, up 35.1% from HKD 545,962,000 in 2021[14]. - Distribution segment revenue for 2022 was HKD 482,300,000, an increase of 35.4% from HKD 356,060,000 in 2021[14]. - Revenue from Mainland China increased to HKD 750,878,000 in 2022, up 34.3% from HKD 558,847,000 in 2021[18]. - Revenue in Hong Kong increased by 42.8% to HKD 321.6 million, attributed to an optimized product mix[44]. - Revenue from other markets, including Singapore, surged by 111.0% to HKD 19.2 million, following the acquisition of Fu Qing Chinese Medical Trading Pte. Limited[44]. Dividends and Earnings Per Share - The board declared a final cash dividend of HKD 0.03 per ordinary share for the fiscal year 2022, compared to no dividend in 2021[2]. - The company reported a basic and diluted earnings per share of HKD 0.06 for 2022, compared to a loss per share of HKD 0.02 in 2021[4]. - Basic earnings per share for 2022 was 6 HK cents, a recovery from a loss of 2 HK cents per share in 2021[25]. - The company plans to distribute a final dividend of 3 HK cents per share, totaling HKD 24,000,000 for 2022[28]. Assets and Liabilities - Total assets as of December 31, 2022, amounted to HKD 1,012.1 million, an increase from HKD 881.5 million in 2021[5]. - Total liabilities increased to HKD 718.96 million in 2022 from HKD 620.2 million in 2021[6]. - Current assets rose to HKD 829.65 million in 2022, compared to HKD 692.7 million in 2021[5]. - Trade receivables increased to HKD 256,213,000 in 2022 from HKD 204,971,000 in 2021[28]. - Trade payables decreased slightly to HKD 302.8 million in 2022 from HKD 306.6 million in 2021[31]. Strategic Initiatives - The company continues to focus on the distribution and retail of health and lifestyle-related products[8]. - The company aims to continue expanding its e-commerce business and explore new markets in Southeast Asia[36]. - The company plans to continue its dual-channel strategy to drive growth in mainland China, Hong Kong, and Macau, while actively expanding in Southeast Asia[42]. - The company has established strong online and offline sales networks, supplying over 1,500 products from more than 100 local and overseas brands[34]. - A strategic cooperation agreement was signed with Biotropics Malaysia to leverage brand management expertise and enhance product visibility in Greater China[41]. Operational Costs and Expenses - The company incurred a cost of goods sold of HKD 924,647,000 in 2022, compared to HKD 737,171,000 in 2021[22]. - Sales and distribution expenses rose by 25.0% to HKD 121.4 million, up from HKD 97.2 million in the previous fiscal year, primarily due to increased e-commerce sales and related marketing costs[45]. - Financial costs increased by 80.8% to HKD 11.3 million, up from HKD 6.3 million in the previous fiscal year, attributed to higher interest-bearing bank borrowings and rising interest rates[45]. - Total employee expenses for the fiscal year were approximately HKD 53.7 million, slightly up from HKD 53.4 million in the previous year, with a total employee count of 179 as of December 31, 2022[51]. Future Outlook - The company expects a rebound in offline sales as travel and social activities resume in 2023, boosting local consumption and confidence[35]. - The company anticipates a significant increase in sales of hair care products due to rising consumer awareness and an aging population[39]. - The company expects a gradual recovery of offline distribution business to pre-pandemic levels as travel restrictions ease[42]. Compliance and Governance - The company has fully complied with the corporate governance code, except for a deviation regarding the separation of roles between the chairman and the CEO[59]. - The auditor confirmed that the financial figures in the preliminary announcement align with the audited financial statements for the year ended December 31, 2022[63].
满贯集团(03390) - 2022 - 年度业绩